Weight Loss
Compounded Tirzepatide
Physician-prescribed compounded tirzepatide with dual GIP/GLP-1 action.
Pricing
$219 per month intro for your first quarter ($657), billed quarterly — $299/mo after.
How it works
Three steps to your first shipment
01
Free online questionnaire
Answer questions about your health history and goals. Takes about 10 minutes — no appointment needed.
02
Physician review
A licensed US physician reviews your case and confirms whether you're a candidate within 24–48 hours.
03
Free discreet delivery
Your medication is compounded by a licensed US pharmacy and shipped to your door at no extra cost.
Overview
What is Tirzepatide?
Compounded tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonist. As the first of its class, tirzepatide activates two separate hormone pathways simultaneously, resulting in superior weight loss compared to GLP-1 monotherapy. Clinical trials (SURMOUNT-1) demonstrated average weight loss of 20–22% body weight — the highest ever recorded in a pharmaceutical weight-loss trial.
Mechanism of action
How it works
Tirzepatide activates both GIP and GLP-1 receptors. GLP-1 activation suppresses appetite and slows digestion; GIP activation further enhances insulin sensitivity and may directly affect fat storage in adipose tissue. The combined dual-receptor agonism produces synergistic weight loss effects that exceed those of GLP-1 agents alone.
Clinical benefits
What patients experience
Average 20–22% reduction in body weight in clinical trials
Dual mechanism targeting two separate hormone pathways
Stronger appetite suppression than single-agent GLP-1 therapy
Significant improvement in blood sugar and insulin sensitivity
Favorable cardiovascular risk profile
Once-weekly subcutaneous injection
Free intake questionnaire · Physician review within 24–48 hours
Safety information
Potential side effects
- Nausea (most common, especially when titrating up)
- Diarrhea
- Vomiting
- Constipation
- Abdominal pain
- Decreased appetite
- Rare: pancreatitis, gallbladder disease
Who should not use this
Contraindications
- Personal or family history of medullary thyroid carcinoma (MTC)
- Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
- Pregnancy or breastfeeding
- Hypersensitivity to tirzepatide
- Severe GI motility disorders
This list is not exhaustive. A licensed physician will review your complete medical history before prescribing. Do not self-prescribe.
Common questions
About Tirzepatide
Ready to start your Tirzepatide program?
Complete a free intake questionnaire. A licensed physician will review your case and respond within 24–48 hours.
Get started — $219/mo$219 per month intro for your first quarter ($657), billed quarterly — $299/mo after. Cancel anytime.
Licensed US physicians · Licensed compounding pharmacy · HIPAA-secure · Available in 47 states